Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

A recent study has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue ...

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration ...

THE001, a thermosensitive doxorubicin liposome for soft tissue sarcomas, received FDA orphan drug designation, offering ...

An AI-based model may improve pediatric sarcoma subtyping, according to research presented by Adam Thiesen, presented at the AACR Annual Meeting 2025.

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS ...

Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft ...

Natera has announced findings from a study evaluating its personalised tumour-informed molecular residual disease (MRD) test, Signatera, in individuals with soft tissue and bone sarcomas.

Researchers used precision medicine platform, Quadratic Phenotypic Optimisation Platform (QPOP), to predict treatment response and identify effective drug combinations for soft tissue sarcomas (STS).